SomnoMed offers oral appliances designed to treat obstructive sleep apnea. These devices are intended to move the jaw and tongue forward during sleep to open up the airway.

SomnoMed Limited, together with its subsidiaries, engages in the production and sale of devices for the oral treatment of sleep related disorders in Europe, North America, and the Asia Pacific region. It offers SomnoDent, an oral appliance for obstructive sleep apnea; SomnoBrux, a dental guard for the treatment of teeth grinding damage; SomMorning Repositioner, which help return mandible back to its pre-treatment centric position; and SomTabs for cleaning oral devices. The company was incorporated in 1987 and is headquartered in Crows Nest, Australia.

COM:SOMNOMED

SomnoMed

Last Close

0.43

25/09 05:10

Market Cap

77.80M

Beta: -

Volume Today

23.90K

Avg: -

locale

market

industry

website

ipo date

competitor of

Metrics